Table 2.
Susceptibility Testing Results of Klebsiella pneumoniae Isolates to Antimicrobial Agents
| Antimicrobial Agent | Klebsiella pneumoniae (n=21) | ||
|---|---|---|---|
| S | I | R | |
| Amikacin | 11 (52.4%) | 0 | 10 (47.6%) |
| Ampicillin | 0 | 0 | 21 (100%) |
| Piperacillin‐tazobactam | 0 | 0 | 21 (100%) |
| Imipenem | 0 | 0 | 21 (100%) |
| Meropenem | 0 | 0 | 21 (100%) |
| Cefoperazone‐sulbactam | 0 | 1 (4.8%) | 20 (95.2%) |
| Cefepime | 0 | 0 | 21 (100%) |
| Aztreonam | 0 | 0 | 21 (100%) |
| Levofloxacin | 0 | 0 | 21 (100%) |
| Trimethoprim‐sulfamethoxazole | 16 (76.2%) | 0 | 9 (42.8%) |
| Tigecycline | 19 (90.5%) | 0 | 2 (9.5%) |
| Polymyxin B | 20 (95.2%) | 0 | 1 (4.8%) |
| Ceftazidime Avibactam | 21 (100%) | 0 | 0 |